Branch Retinal Artery Occlusion (BRAO) Explained
What Is Branch Retinal Artery Occlusion?
BRAO is a form of retinal vascular emergency in which a branch of the central retinal artery becomes partially or completely obstructed, cutting off the blood supply to a section of the retina.
The retina receives its blood supply primarily through the central retinal artery, which enters the eye through the optic nerve and then divides into upper and lower branches. These branches further split into smaller arterioles that nourish the inner layers of the retina, including the ganglion cells responsible for transmitting visual signals to the brain. When one of these branches is blocked, the retinal tissue it supplies begins to suffer ischemic damage within minutes.
The most common cause of BRAO is an embolus, a small particle of cholesterol, calcium, or clotted blood, that travels from elsewhere in the body and lodges in a retinal branch artery. These emboli frequently originate from atherosclerotic plaques in the carotid arteries or from the heart in patients with valve disease or atrial fibrillation. Once the embolus blocks the vessel, the retinal tissue downstream is deprived of oxygen. Irreversible inner-retinal injury can begin after roughly ninety minutes without adequate blood flow, making timely recognition critical.
While BRAO affects only a branch of the retinal artery and typically causes partial vision loss in one section of the visual field, a central retinal artery occlusion blocks the main trunk and can result in severe, widespread vision loss across the entire eye. BRAO generally carries a more favorable visual prognosis than its central counterpart. Despite the better outlook, both conditions are considered stroke equivalents and require the same urgent systemic evaluation.
What Causes BRAO?
Several cardiovascular, hematologic, and lifestyle factors can contribute to the development of a branch retinal artery occlusion.
The majority of BRAO cases result from emboli that originate in the carotid arteries or the heart. Cholesterol emboli, also called Hollenhorst plaques, are the most frequently identified type and appear as bright, refractile particles within the retinal vasculature. Calcific emboli from damaged heart valves and fibrin-platelet emboli related to blood clotting are also common sources. Widespread atherosclerosis, the gradual buildup of fatty deposits within artery walls, is the underlying process that generates most of these emboli.
High blood pressure is one of the strongest risk factors for retinal artery occlusion. Diabetes, elevated cholesterol, coronary artery disease, carotid artery stenosis, and atrial fibrillation all increase the likelihood of embolic events reaching the retinal circulation. Because BRAO shares these risk factors with stroke, the condition is treated as a warning sign for potentially life-threatening cerebrovascular disease. Patients who experience BRAO face an elevated risk of future stroke, making prompt cardiovascular evaluation essential.
In younger patients or those without traditional cardiovascular risk factors, BRAO may be caused by vasculitis, clotting disorders such as antiphospholipid syndrome or protein S deficiency, sickle cell disease, or migraine-related vasospasm. Oral contraceptive use, hyperhomocysteinemia, and inflammatory conditions such as giant cell arteritis are additional considerations that our retina specialists evaluate when the typical risk profile does not apply.
Symptoms of Branch Retinal Artery Occlusion
BRAO typically presents with a sudden, painless change in vision that corresponds to the area of the retina affected by the blocked artery.
Most patients notice an abrupt loss of vision in a specific portion of their visual field. Unlike conditions that cause generalized blurriness, BRAO creates a well-defined area of missing or dimmed vision, often described as a curtain, shadow, or dark patch covering part of the field of view. The onset is usually immediate and occurs without pain, redness, or external signs of a problem.
The specific pattern of vision loss depends on which branch artery is occluded. An upper branch occlusion typically causes a lower visual field defect, and a lower branch occlusion produces an upper field defect. When the blocked artery supplies the area near the fovea, the central point of sharpest vision, patients may experience a noticeable drop in visual acuity along with difficulty reading or recognizing faces.
In some cases, the embolus dislodges on its own and blood flow is restored before permanent retinal damage occurs. This transient form of BRAO may cause vision loss that lasts only seconds to minutes before resolving completely. While recovery in these episodes is encouraging, transient BRAO still signals an underlying embolic source and carries the same stroke risk as a permanent occlusion. Any episode of sudden, unexplained vision loss warrants urgent evaluation, even if the symptoms seem to improve.
How BRAO Is Diagnosed
Diagnosing BRAO involves a combination of clinical eye examination, advanced retinal imaging, and a systemic workup to identify the embolic source and assess stroke risk.
During a dilated eye exam, our retina specialists look for characteristic signs of BRAO, including a wedge-shaped area of retinal whitening, or pallor, in the distribution of the affected branch artery. A visible embolus lodged at a vessel bifurcation is sometimes seen and helps confirm the diagnosis. The surrounding retinal tissue typically appears normal, creating a clear contrast between the ischemic zone and the healthy retina.
Optical coherence tomography (OCT) provides detailed cross-sectional images of the retinal layers and plays an important role in evaluating BRAO at every stage. In the acute phase, OCT reveals increased reflectivity and thickening of the inner retinal layers due to ischemic edema. Over time, these layers thin as the damaged tissue atrophies, helping us distinguish acute from chronic events and monitor recovery.
Fluorescein angiography (FA) involves injecting a safe fluorescent dye into a vein and photographing the dye as it circulates through the retinal vessels. In BRAO, FA demonstrates delayed or absent filling of the affected branch artery, a slowly advancing dye front, and areas of retinal non-perfusion. This test helps define the full extent of the vascular blockage and identify any areas at risk for complications such as neovascularization.
Because BRAO is classified as a stroke equivalent, a thorough systemic evaluation is one of the most important steps following diagnosis. Current guidelines recommend carotid ultrasound to assess for atherosclerotic plaque, echocardiography to evaluate cardiac sources of emboli, and blood pressure monitoring. Additional laboratory tests may include a complete blood count, lipid panel, blood glucose, erythrocyte sedimentation rate, and coagulation studies. Referral to a stroke center or internist is appropriate, ideally within the first few days, to reduce the risk of a subsequent cerebrovascular event.
Frequently Asked Questions
There is currently no treatment that reliably reverses established retinal damage from BRAO. In the very early stages, within roughly ninety minutes of symptom onset, certain emergency measures such as ocular massage or anterior chamber paracentesis may be attempted to dislodge the embolus, though evidence of their effectiveness is limited. The primary focus of management is a thorough cardiovascular workup and controlling systemic risk factors such as hypertension, diabetes, and high cholesterol. If abnormal new blood vessels develop as a complication, anti-VEGF injections or laser photocoagulation may be recommended.
BRAO can cause lasting vision loss, though the extent depends on which branch artery is involved and whether the fovea is affected. In permanent BRAO, studies show that approximately 74% of patients present with visual acuity of 20/40 or better, and about 89% maintain that level on follow-up. However, patients whose initial acuity is 20/100 or worse have a much lower chance of significant improvement. Transient BRAO, where the blockage clears quickly, generally has a better visual outcome.
BRAO is most common in adults over sixty and occurs slightly more often in men. The strongest risk factors are high blood pressure, atherosclerosis, elevated cholesterol, diabetes, carotid artery disease, and heart conditions that can produce emboli such as atrial fibrillation or valvular disease. Smoking significantly increases risk as well. In younger patients, clotting disorders, vasculitis, and autoimmune conditions should be investigated. Understanding branch artery occlusion and its risk factors can help you take preventive steps.
Visual prognosis correlates strongly with the initial visual acuity at the time of diagnosis. Patients who present with relatively good vision, 20/40 or better, tend to maintain or improve that level over time. Those with more significant initial vision loss face a more guarded prognosis, as prolonged ischemia causes irreversible damage to the inner retinal layers. Transient BRAO cases, where blood flow is quickly restored, carry the most favorable visual outlook, with nearly all patients retaining good acuity.
Managing the underlying systemic conditions that contribute to BRAO is the cornerstone of prevention. This includes keeping blood pressure, blood sugar, and cholesterol within healthy ranges through medication and lifestyle modifications. Your physician may recommend antiplatelet therapy such as aspirin to reduce the risk of further embolic events. Quitting smoking, maintaining a healthy weight, exercising regularly, and attending scheduled follow-ups with both your internist and our retina specialists all play a role in lowering your risk. Conditions like branch retinal vein occlusion share many of the same vascular risk factors, so these preventive measures protect against multiple threats to your eye health.
Any episode of sudden, painless vision loss, whether partial or complete, temporary or persistent, should be treated as an urgent matter. Even if your vision returns to normal within minutes, this may indicate a transient occlusion that signals a serious underlying condition. You should seek same-day evaluation from an eye care professional who can perform a dilated examination and arrange the appropriate workup. Occasionally, new floaters or flashes of light accompany vascular events in the eye, so any new or unusual visual symptoms deserve prompt attention.
What our Patients say
4.8
Reviews
(3,408)